AVL200 IOL for Treatment of Cataract and Presbyopia

Last updated: July 26, 2023
Sponsor: Atia Vision
Overall Status: Active - Recruiting

Phase

N/A

Condition

Vision Loss

Eye Disorders/infections

Presbyopia

Treatment

AVL200 IOL

Clinical Study ID

NCT05627700
CP100962
  • Ages > 40
  • All Genders

Study Summary

This study is to evaluate the performance of the AVL200 IOL in terms of visual function improvement over a range of focal points. Participants meeting eligibility criteria will undergo cataract surgery with implantation of the AVL200 intraocular lens (IOL), then be followed through 1 year postoperatively. Postoperative assessments include safety and visual function.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Visually significant cataract
  • Best corrected distance visual acuity between 20/40 and 20/200
  • Potential distance visual acuity of 20/32 or better
  • Corneal astigmatism ≤ 1.5 diopters

Exclusion

Exclusion Criteria:

  • Use of medication that could affect accommodation
  • Previous corneal surgery or significant corneal abnormalities
  • Ocular pathology or degenerative disorder having potential to impair visual acuity
  • Pupil abnormality
  • Intraoperative cataract surgery complications that could affect IOL implantation orpositioning

Study Design

Total Participants: 60
Treatment Group(s): 1
Primary Treatment: AVL200 IOL
Phase:
Study Start date:
July 25, 2022
Estimated Completion Date:
January 31, 2026

Connect with a study center

  • Dr Agarwal's Eye Hospital

    Chennai, Tamal Nadu 600018
    India

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.